Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease
about
Chondroitin sulfate proteoglycans in the nervous system: inhibitors to repairAstrogliosis in CNS pathologies: is there a role for microglia?Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: role of tumor necrosis factor- alphaThe role of oxidative stress in Parkinson's diseaseGlial cells as intrinsic components of non-cell-autonomous neurodegenerative diseaseSimvastatin inhibits the activation of p21ras and prevents the loss of dopaminergic neurons in a mouse model of Parkinson's diseaseNeuroprotective and anti-inflammatory properties of a coffee component in the MPTP model of Parkinson's diseaseTranslocator protein 18 kDa (TSPO): molecular sensor of brain injury and repairSerum antibodies from Parkinson's disease patients react with neuronal membrane proteins from a mouse dopaminergic cell line and affect its dopamine expressionTFP5/TP5 peptide provides neuroprotection in the MPTP model of Parkinson's diseaseChronic Stress and Glucocorticoids: From Neuronal Plasticity to NeurodegenerationNeuroimmunological processes in Parkinson's disease and their relation to α-synuclein: microglia as the referee between neuronal processes and peripheral immunityImpaired Brain Dopamine and Serotonin Release and Uptake in Wistar Rats Following Treatment with CarboplatinCB2 receptor activation prevents glial-derived neurotoxic mediator production, BBB leakage and peripheral immune cell infiltration and rescues dopamine neurons in the MPTP model of Parkinson's disease.Differential Protein Distribution between the Nucleus and Mitochondria: Implications in AgingInhibition of the cyclooxygenase isoenzymes COX-1 and COX-2 provide neuroprotection in the MPTP-mouse model of Parkinson's diseaseAcute neuroimmune modulation attenuates the development of anxiety-like freezing behavior in an animal model of traumatic brain injuryDevelopmental exposure to manganese increases adult susceptibility to inflammatory activation of glia and neuronal protein nitrationPesticides, microglial NOX2, and Parkinson's diseaseEnhanced astrocytic nitric oxide production and neuronal modifications in the neocortex of a NOS2 mutant mouseStriatal neuroinflammation promotes Parkinsonism in ratsThe nitric oxide-cyclic GMP pathway regulates FoxO and alters dopaminergic neuron survival in DrosophilaDiscovery of a natural product-like iNOS inhibitor by molecular docking with potential neuroprotective effects in vivoEffects of Ranolazine on Astrocytes and Neurons in Primary CultureAltered dopamine signaling and MPTP resistance in mice lacking the Parkinson's disease-associated GPR37/parkin-associated endothelin-like receptorBax ablation prevents dopaminergic neurodegeneration in the 1-methyl- 4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's diseaseDisease-toxicant interactions in Parkinson's disease neuropathologyAberrant protein S-nitrosylation contributes to the pathophysiology of neurodegenerative diseasesRegulatory T cells attenuate Th17 cell-mediated nigrostriatal dopaminergic neurodegeneration in a model of Parkinson's disease.Neuromelanin activates microglia and induces degeneration of dopaminergic neurons: implications for progression of Parkinson's diseasePomegranate juice exacerbates oxidative stress and nigrostriatal degeneration in Parkinson's disease.Capsaicin prevents degeneration of dopamine neurons by inhibiting glial activation and oxidative stress in the MPTP model of Parkinson's disease.Development of urea and thiourea kynurenamine derivatives: synthesis, molecular modeling, and biological evaluation as nitric oxide synthase inhibitors.Macrophage antigen complex-1 mediates reactive microgliosis and progressive dopaminergic neurodegeneration in the MPTP model of Parkinson's disease.Nitrated alpha-synuclein immunity accelerates degeneration of nigral dopaminergic neurons.Neuroprotective effects of the triterpenoid, CDDO methyl amide, a potent inducer of Nrf2-mediated transcription.Neuroprotective effects of compounds with antioxidant and anti-inflammatory properties in a Drosophila model of Parkinson's diseaseHydrogen in drinking water reduces dopaminergic neuronal loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.Nitrated alpha-synuclein induces the loss of dopaminergic neurons in the substantia nigra of rats.Cyclooxygenase-1 null mice show reduced neuroinflammation in response to beta-amyloid.
P2860
Q21284516-2313463A-435A-46ED-A513-BACC54A1E17FQ23911551-B601CC89-B022-420E-BA82-88513DF88D3DQ23916369-8F5770C8-DD07-4D95-9200-89A26403E1A5Q24307946-F9C32065-D893-45D0-991E-12F749A17786Q24621854-AC38E40F-B6D7-4F15-8E56-B42F037692B4Q24629942-82647C74-A031-4825-BC0B-6D5C9125D1AFQ24630237-0B03F44D-2FBC-4B05-8AFD-A9BD0872CA95Q24644752-3CD98666-26AD-481A-B96D-278CCA3E1E51Q25257546-ABEE6E51-0105-4FC9-92A2-25140D7E5216Q26747606-57CE6D2A-E04E-4D3D-A424-2C3423DB5643Q26748974-CDB27A5D-5C2B-459F-86E6-A4192B337643Q27027973-6BAE621B-E862-414E-98FD-74EB8EDF25E2Q27300384-CC6F3470-BBC0-46DE-BBB4-21096A0ADFDAQ27324500-F61C7A89-D92E-4988-AEBE-C7FD3F681EB2Q28075214-99D6A714-CBEE-4E94-AEF4-B2E89EC78E75Q28175939-73F85858-C06F-4D8F-B32E-94A35F114F81Q28386168-49AD4F29-63B3-442E-A9B2-B8C45160215FQ28392104-155DEAA3-F2CF-421F-B530-406B348AB143Q28397585-9CFAD1D3-BFD4-4342-80B9-EB2EF9AC8C90Q28469285-3841BE83-56CD-4657-89E7-05E35C97D20DQ28475466-E022D354-B2D0-4C85-8089-BEF67EAD5FACQ28481326-801F0945-2A99-49E3-9B24-C6B89E06395BQ28541741-E98FBF2E-E545-4BA6-A191-C5DCF59BEC8BQ28550579-628CCDAA-D041-4A0C-B128-BE5B37912C09Q28588013-327BA2D6-1664-4D3C-BEB3-6EDD02FD0540Q28594269-A05FEBFB-D974-4569-9703-826D29AFDFBCQ29248297-274D0AB4-B98E-4328-89D3-951CBBD6B6E5Q30372906-A8C6226F-F471-4CD3-BA07-E5110F1FCB78Q30493249-7BF62116-9BB4-441B-A5D8-E0946CEAF3CDQ30537842-1030509F-D9BC-4969-9508-F606C50F87D8Q30573637-21259326-D1A6-4992-A968-8A08A86A95C2Q30844366-DEBC7773-2853-4CE7-AEAC-E09CECE2AC68Q30914542-0B0303B1-233D-4EC0-89A4-E80303B1C614Q33112256-48DC3501-A0AD-4990-8C9B-AE1A751AE30CQ33312931-B6A338FC-EC4A-4692-BAD1-46EA983B74B5Q33457162-1A263B40-FD5B-4396-BB2F-648AAFB24AFEQ33499111-2BD6A704-7278-4C3E-AD14-41330BA467FAQ33507513-F01D7CA6-56F6-4982-BDA9-337771ACE859Q33553317-835C9C60-B503-462F-BDF8-E9B8FDDCDC81Q33588687-ACCCFC7F-EDF3-4ED0-9325-58CB60452FD0
P2860
Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease
description
article
@en
im Dezember 1999 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в грудні 1999
@uk
ലേഖനം
@ml
name
Inducible nitric oxide synthas ...... PTP model of Parkinson disease
@en
Inducible nitric oxide synthas ...... PTP model of Parkinson disease
@nl
type
label
Inducible nitric oxide synthas ...... PTP model of Parkinson disease
@en
Inducible nitric oxide synthas ...... PTP model of Parkinson disease
@nl
prefLabel
Inducible nitric oxide synthas ...... PTP model of Parkinson disease
@en
Inducible nitric oxide synthas ...... PTP model of Parkinson disease
@nl
P2093
P50
P356
P1433
P1476
Inducible nitric oxide synthas ...... PTP model of Parkinson disease
@en
P2093
Allen S. Mandir
Gabriel T. Liberatore
Slobodanka Vukosavic
Valina L. Dawson
W. Geoffrey McAuliffe
P2888
P304
P356
10.1038/70978
P407
P577
1999-12-01T00:00:00Z